Summary
Robert F. Kennedy Jr. is overhauling vaccine guidelines as HHS Secretary while Florida plans to eliminate all mandates. The changes raise major public health concerns and could pressure vaccine makers like Pfizer and Moderna while opening doors for smaller biotech players.
Market Recap
Market Movers
- 📈 US Non-Farm Employment Change: Sep 5, 2025
📚 Deep Dive 📚
RFK Jr. Shake-Up: Vaccine Policy Overhaul Hits Health and Markets
Rise of RFK Jr. at Health’s Helm
In February 2025, Robert F. Kennedy Jr.—yes, the same RFK known for his environmental and anti-vaccine advocacy—became the U.S. Secretary of Health and Human Services under President Trump. Shortly after being sworn in, he launched a reorganization dubbed “Make America Healthy Again” (MAHA), merging several federal health agencies into the new Administration for a Healthy America and slashing thousands of jobs—especially across the CDC and FDA—ostensibly to boost efficiency.
How Vaccine Guidelines Are Getting Flipped
RFK Jr. has made sweeping moves:
- Fired all 17 members of the CDC’s Advisory Committee on Immunization Practices (ACIP) and replaced them with vaccine-skeptical members.
- ACIP is set to meet around September 18 to vote on scheduling for vaccines like hep B, MMRV, and RSV.
- Approved removal of thiomersal (a preservative) from flu vaccines.
- Pulled $500 million in funding for 22 mRNA vaccine projects (COVID, flu, H5N1).
- Launched a revived childhood vaccine safety task force under NIH director Jay Bhattacharya.
- Revised CDC guidance on COVID-19 vaccines—removing recommendations for kids and pregnant women.
These changes have sparked turmoil: CDC morale is collapsing, officials are resigning, and critics warn decades of trust in public health could unravel.
Florida Goes All In: No More Vaccine Mandates
Meanwhile, Florida's health leaders are taking things further. Surgeon General Joseph Ladapo, backed by Governor DeSantis, announced the state’s intent to end all vaccine mandates, including school requirements like MMR, DTaP, polio, and chickenpox shots. Ladapo even called mandates “slavery.”
Medical groups like the AMA warn this could trigger outbreaks and worsen community health risks.
Reading Made Easy
- Who’s changing the rules? RFK Jr. and Florida officials.
- What’s changing? Vaccine boards, funding, guidelines, and school mandates.
- Why care? The shifts disrupt public health norms and ripple into financial markets.
Markets: Who Wins, Who Loses?
- Moderna (MRNA): ~$24.18
- Pfizer (PFE): ~$24.51
Potential Market Shockwaves
| Sector | Impact | Why It Matters |
|---|---|---|
| mRNA Vaccine Makers (Moderna, Pfizer, others) | Negative | Cuts in mRNA funding and skepticism could depress vaccine revenues and R&D pipelines. |
| Companies with Alternative Approaches | Potential Positive | Whole-virus or universal vaccine strategies may benefit under new policies. |
| Pharma Infrastructure & Suppliers | Mixed | Reduced CDC/FDA workforce may slow approvals, affecting suppliers. |
| Emerging Biotechs | Risk & Reward | Some may thrive with novel approaches; others may lose funding. |
| Health Insurance & Clinics | Uncertain | Fragmented guidelines could disrupt coverage and demand. |
Wrap-Up: Why This Matters to You
- RFK Jr.’s overhaul is rewriting decades of public health policy. (about time imo)
- Florida’s repeal of mandates may inspire other states, deepening polarization.
- Markets face volatility: giants like Pfizer and Moderna could struggle, while niche biotech players may find opportunity.
- At its core, this battle is about science, trust, and ideology—and the outcome will shape both public health and market dynamics.
My Take:
I’m happy to see these changes taking shape. The U.S. healthcare system needs a reset, and for too long big pharma has had a stranglehold on how things operate—often with little regard for how it impacts everyday communities and individuals.
That said, my eyes are firmly on biotech for opportunities going forward. Right now, we have HIMS calls on the table while still holding the stock, and we’re also holding UNH shares.
Keep it locked in our Discord for any new additions to stocks or options!
📞 Book a Call with GAR Capital
Want to learn how we’re positioning in this market and how you can take advantage of the opportunities ahead? 📈
Our Masterclass gives you private 1-on-1 coaching with Carlos G plus access to signals, strategies, and all future upgrades.
👉 Book your free call today and see how GAR Capital can help you grow. Lock in!